Carisma Therapeutics, Inc. (CARM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 45.25M | 0 | 3.73M | 3.65M | 3.38M | 9.2M | 3.4M | 4.29M | 3.83M | 3.56M | 3.24M | 3.73M | 2.58M | 2.7M | 822K | 20M | 0 | 0 | 4.31M | 0 |
| Revenue Growth % | 1236.78% | -100% | 9.77% | -14.83% | -11.55% | 158.34% | 4.75% | 14.96% | 48.45% | 31.71% | 294.53% | -81.34% | - | - | -80.93% | - | -100% | - | - | - |
| Cost of Goods Sold | 0 | 356K | 0 | 669K | 0 | 15.31M | 17.46M | 2.08M | 19.55M | 18.52M | 705K | 18.08M | 15.56M | 14.21M | 218K | 11K | 8.57M | 8.01M | 8.01M | 0 |
| COGS % of Revenue | - | - | - | 18.31% | - | 166.43% | 514.04% | 48.59% | 510.87% | 520.17% | 21.74% | 484.64% | 603.45% | 525.79% | 26.52% | 0.06% | - | - | 185.87% | - |
| Gross Profit | 45.25M | -356K | 3.73M | 2.98M | 3.38M | -6.11M | -14.06M | 2.21M | -15.72M | -14.96M | 2.54M | -14.35M | -12.98M | -11.51M | 604K | 19.99M | -8.57M | -8.01M | -3.7M | 0 |
| Gross Margin % | 100% | - | 100% | 81.69% | 100% | -66.43% | -414.04% | 51.41% | -410.87% | -420.17% | 78.26% | -384.64% | -503.45% | -425.79% | 73.48% | 99.94% | - | - | -85.87% | - |
| Gross Profit Growth % | 1236.78% | 94.17% | 126.51% | 35.33% | 121.53% | 59.15% | -654.18% | 115.36% | -21.15% | -29.97% | 320.2% | -171.79% | -51.36% | -43.66% | 116.32% | - | -176.32% | - | -11838.71% | - |
| Operating Expenses | 1.44M | 5.42M | 13.06M | 20.84M | 16.53M | 5.56M | 5.45M | 24.66M | 6.62M | 6.01M | 25.51M | 971K | 3.77M | 2.42M | 10.76M | 15.63M | 1.68M | 1.09M | 36.23M | 8.99M |
| OpEx % of Revenue | 3.17% | - | 350.31% | 570.46% | 488.3% | 60.45% | 160.29% | 574.84% | 172.98% | 168.74% | 786.62% | 26.03% | 146.31% | 89.68% | 1309% | 78.13% | - | - | 840.63% | - |
| Selling, General & Admin | 1.24M | 3.35M | 3.91M | 7.88M | 5.2M | 5.56M | 5.45M | 5.24M | 6.62M | 6.01M | 8.87M | 971K | 3.77M | 2.42M | 1.99M | 8.6M | 1.68M | 1.09M | 5.29M | 3.42M |
| SG&A % of Revenue | 2.74% | - | 104.77% | 215.66% | 153.71% | 60.45% | 160.29% | 122.17% | 172.98% | 168.74% | 273.48% | 26.03% | 146.31% | 89.68% | 242.46% | 42.98% | - | - | 122.81% | - |
| Research & Development | 197K | 2.42M | 9.16M | 15.58M | 11.33M | 15.31M | 17.46M | 19.41M | 19.55M | 18.52M | 16.64M | 18.08M | 15.56M | 14.21M | 8.77M | 7.03M | 8.57M | 8.01M | 6.05M | 5.57M |
| R&D % of Revenue | 0.44% | - | 245.54% | 426.44% | 334.59% | 166.43% | 514.04% | 452.67% | 510.87% | 520.17% | 513.14% | 484.64% | 603.45% | 525.79% | 1066.55% | 35.14% | - | - | 140.32% | - |
| Other Operating Expenses | 0 | -356K | 0 | -1000K | 0 | -1000K | -1000K | 0 | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | 0 | 0 | -1000K | -1000K | 1000K | 0 |
| Operating Income | 43.81M | -5.78M | -9.33M | -17.86M | -13.14M | -11.67M | -19.51M | -22.45M | -22.34M | -20.96M | -22.97M | -15.32M | -16.75M | -13.93M | -10.16M | 4.36M | -10.25M | -9.1M | -13.18M | -8.99M |
| Operating Margin % | 96.83% | - | -250.31% | -488.78% | -388.3% | -126.89% | -574.33% | -523.43% | -583.85% | -588.9% | -708.36% | -410.67% | -649.77% | -515.46% | -1235.52% | 21.82% | - | - | -305.68% | - |
| Operating Income Growth % | 433.34% | 50.49% | 52.16% | 20.47% | 41.17% | 44.34% | 15.07% | -46.52% | -33.39% | -50.47% | -126.19% | -451.1% | -63.41% | -53.13% | 22.91% | 148.56% | -233.37% | -15.47% | -6.98% | -3.07% |
| EBITDA | 44.72M | -5.42M | -8.67M | -17.19M | -12.41M | -11.41M | -17.82M | -20.37M | -21.65M | -20.25M | -22.27M | -14.62M | -16.03M | -13.69M | -9.94M | 4.38M | -10.07M | -8.95M | -13.14M | -8.96M |
| EBITDA Margin % | 98.82% | - | -232.58% | -470.46% | -366.53% | -124.12% | -524.49% | -474.84% | -565.69% | -568.82% | -686.62% | -391.77% | -621.64% | -506.4% | -1209% | 21.88% | - | - | -304.99% | - |
| EBITDA Growth % | 460.42% | 52.5% | 51.32% | 15.61% | 42.69% | 43.63% | 19.98% | -39.33% | -35.09% | -47.94% | -124.06% | -434.1% | -59.18% | -52.89% | 24.4% | 148.85% | -230.75% | -14.05% | -7.01% | -3.38% |
| D&A (Non-Cash Add-back) | 0 | 356K | 661K | 669K | 737K | 255K | 1.69M | 2.08M | 695K | 715K | 705K | 705K | 725K | 245K | 218K | 11K | 183K | 146K | 30K | 30K |
| EBIT | 44.72M | -5.78M | -9.33M | -17.64M | -13.14M | -11.67M | -19.51M | -22.45M | -22.34M | -20.96M | -23.06M | -15.32M | -16.75M | -13.93M | -10.71M | 8.94M | -10.25M | -9.1M | -55.22M | -14.7M |
| Net Interest Income | 0 | 470K | 68K | 220K | 442K | 0 | 532K | 1.29M | 941K | 1.18M | -1.48M | -867K | -908K | -771K | -599K | 0 | 0 | 3.5K | 0 | 0 |
| Interest Income | 0 | 470K | 68K | 220K | 442K | 0 | 532K | 1.29M | 941K | 1.18M | - | - | - | - | 557K | 0 | 0 | 3.5K | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 1.48M | 867K | 908K | 771K | 1.16M | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 903K | -4M | 68K | 220K | 442K | 508K | 532K | 1.29M | 941K | 1.18M | -1.56M | -1.42M | -1.58M | -915K | -1.16M | 4.58M | 6K | 3.5K | -48.16M | -5.71M |
| Pretax Income | 44.72M | -9.77M | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -21.16M | -21.4M | -19.79M | -24.53M | -16.74M | -18.33M | -14.85M | -11.31M | 8.94M | -10.24M | -9.1M | 1.79M | -14.7M |
| Pretax Margin % | 98.82% | - | -248.48% | -482.75% | -375.24% | -121.37% | -558.67% | -493.24% | -559.26% | -555.84% | -756.49% | -448.65% | -710.9% | -549.32% | -1376.16% | 44.72% | - | - | 41.47% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -197K | 0 | 88K | 109K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 288K | 313K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.93% | 0% | -0.44% | -0.44% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 16.11% | -2.13% |
| Net Income | 44.72M | -9.77M | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -20.96M | -21.4M | -19.88M | -24.64M | -16.74M | -18.33M | -14.85M | -11.31M | 8.94M | -10.24M | -9.1M | -55.51M | -15.01M |
| Net Margin % | 98.82% | - | -248.48% | -482.75% | -375.24% | -121.37% | -558.67% | -488.65% | -559.26% | -558.31% | -759.85% | -448.65% | -710.9% | -549.32% | -1376.16% | 44.72% | - | - | -1287.98% | - |
| Net Income Growth % | 452.05% | 12.44% | 51.18% | 15.86% | 40.65% | 43.84% | 22.99% | -25.2% | -16.78% | -33.86% | -117.84% | -287.15% | -78.89% | -63.25% | 79.62% | 159.59% | 54.68% | 65.47% | -233.56% | 55.27% |
| Net Income (Continuing) | 44.72M | -9.77M | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -20.96M | -21.4M | -19.88M | -24.64M | -16.74M | -18.33M | -14.85M | -11.31M | 8.94M | -10.24M | -9.1M | -55.51M | -15.01M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.39M | 14.39M | 14.39M | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 | -0.27 | -0.46 | -0.52 | -0.53 | -0.49 | -0.61 | -0.42 | -0.46 | -0.37 | -0.32 | 0.90 | 7.13 | -2.90 | -7.07 | -2.55 |
| EPS Growth % | 445.16% | 14.81% | 52.17% | 19.23% | 41.51% | 44.9% | 24.59% | -23.81% | -15.22% | -32.43% | -90.63% | -146.67% | -106.45% | 87.24% | 95.47% | 135.29% | 285.68% | 38.03% | -193.4% | 58.27% |
| EPS (Basic) | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 | -0.27 | -0.46 | -0.52 | -0.53 | -0.49 | -0.61 | -0.42 | -0.46 | -0.37 | -0.32 | 0.90 | 7.28 | -2.90 | -7.07 | -2.55 |
| Diluted Shares Outstanding | 41.94M | 41.79M | 41.77M | 41.46M | 41.54M | 41.54M | 40.94M | 40.39M | 40.29M | 40.26M | 40.26M | 40.26M | 40.26M | 40.26M | 9.97M | 9.97M | 10.05M | 8.77M | 7.85M | 5.89M |
| Basic Shares Outstanding | 41.79M | 41.79M | 41.77M | 41.46M | 41.54M | 41.54M | 40.94M | 40.39M | 40.29M | 40.26M | 40.26M | 40.26M | 40.26M | 40.26M | 9.97M | 9.97M | 9.84M | 8.77M | 7.85M | 5.89M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |